Literature DB >> 7678116

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma.

J L Baron1, J A Madri, N H Ruddle, G Hashim, C A Janeway.   

Abstract

Cloned CD4 T cell lines that recognize the Ac1-16 peptide of myelin basic protein bound to I-Au were isolated and used to analyze the immunopathogenesis of experimental autoimmune encephalomyelitis (EAE). T helper type 1 (Th1) clones induced disease, while Th2 clones did not. Using variants of a single cloned Th1 line, the surface expression of alpha 4 integrins (very late antigen 4 [VLA-4]) was identified as a major pathogenic factor. Encephalitogenic clones and nonencephalitogenic variants differ by 10-fold in their level of surface expression of alpha 4 integrin and in their ability to bind to endothelial cells and recombinant vascular cell adhesion molecule 1 (VCAM-1). The alpha 4 integrin-high, disease-inducing cloned Th1 T cells enter brain parenchyma in abundance, while alpha 4 integrin-low, nonencephalitogenic Th1 cells do not. Moreover, antibodies to alpha 4 integrin, its ligand VCAM-1, and intercellular adhesion molecule 1 all influence the pathogenicity of this encephalitogenic clone in vivo. The importance of the expression of VLA-4 for encephalitogenicity is not unique to cloned T cell lines, as similar results were obtained using myelin basic protein-primed lymph node T cells. alpha 4 integrin levels did not affect antigen responsiveness or production of the Th1 cytokines interleukin 2, interferon gamma, and lymphotoxin/tumor necrosis factor beta; and antibodies against alpha 4 integrin did not block antigen recognition in vitro. Thus, we conclude that surface expression of alpha 4 integrin is important in CD4 T cell entry into brain parenchyma. A general conclusion of these studies is that alpha 4 integrins may be crucial in allowing activated effector T cells to leave blood and enter the brain and other tissues to clear infections.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678116      PMCID: PMC2190872          DOI: 10.1084/jem.177.1.57

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  55 in total

Review 1.  Physiological and molecular mechanisms of lymphocyte homing.

Authors:  L J Picker; E C Butcher
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

2.  Experimental allergic encephalomyelitis. An encephalitogenic basic protein from bovine myelin.

Authors:  E H Eylar; J Salk; G C Beveridge; L V Brown
Journal:  Arch Biochem Biophys       Date:  1969-06       Impact factor: 4.013

3.  Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes.

Authors:  C B Pettinelli; D E McFarlin
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

4.  Virus plaque-reduction assay for interferon: microplaque and regular macroplaque reduction assays.

Authors:  M P Langford; D A Weigent; G J Stanton; S Baron
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

5.  Genetic characterization of a polymorphic murine cell-surface glycoprotein.

Authors:  J Lesley; I S Trowbridge
Journal:  Immunogenetics       Date:  1982-03       Impact factor: 2.846

6.  ICAM-1-independent lymphocyte transmigration across high endothelium: differential up-regulation by interferon gamma, tumor necrosis factor-alpha and interleukin 1 beta.

Authors:  M J May; A Ager
Journal:  Eur J Immunol       Date:  1992-01       Impact factor: 5.532

7.  Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens.

Authors:  T Springer; G Galfrè; D S Secher; C Milstein
Journal:  Eur J Immunol       Date:  1978-08       Impact factor: 5.532

8.  An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis.

Authors:  N H Ruddle; C M Bergman; K M McGrath; E G Lingenheld; M L Grunnet; S J Padula; R B Clark
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

9.  The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules.

Authors:  M Rodrigues; R S Nussenzweig; P Romero; F Zavala
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

10.  Antigen-reactive T cell clones. I. Transcomplementing hybrid I-A-region gene products function effectively in antigen presentation.

Authors:  M Kimoto; C G Fathman
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  216 in total

Review 1.  The role of self-recognition in receptor repertoire development. Members of the Janeway Laboratory.

Authors:  C A Janeway
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  The role of TNFalpha and lymphotoxin in demyelinating disease.

Authors:  C Lock; J Oksenberg; L Steinman
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

3.  Encephalitogenic lymphoblast recruitment to resting CNS microvasculature: a natural immunosurveillance mechanism?

Authors:  R Alon
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

4.  Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels.

Authors:  P Vajkoczy; M Laschinger; B Engelhardt
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 5.  Isoforms of vitamin E differentially regulate inflammation.

Authors:  Joan M Cook-Mills; Christine A McCary
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-12       Impact factor: 2.895

6.  VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis.

Authors:  Blythe C Dillingham; Susan M Knoblach; Gina M Many; Brennan T Harmon; Amanda M Mullen; Christopher R Heier; Luca Bello; John M McCall; Eric P Hoffman; Edward M Connor; Kanneboyina Nagaraju; Erica K M Reeves; Jesse M Damsker
Journal:  Cell Mol Neurobiol       Date:  2014-11-13       Impact factor: 5.046

7.  T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1.

Authors:  Weici Zhang; Yoko Ono; Yoshinori Miyamura; Christopher L Bowlus; M Eric Gershwin; Emanual Maverakis
Journal:  J Autoimmun       Date:  2011-06-01       Impact factor: 7.094

8.  Anaphylaxis and mortality induced by treatment of mice with anti-VLA-4 antibody and pertussis toxin.

Authors:  Niannian Ji; Nagarjun Rao; Neal M Guentzel; Bernard P Arulanandam; Thomas G Forsthuber
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

9.  An increase in tolerogenic dendritic cell and natural regulatory T cell numbers during experimental autoimmune encephalomyelitis in Rras-/- mice results in attenuated disease.

Authors:  Avijit Ray; Sreemanti Basu; Nichole M Miller; Andrew M Chan; Bonnie N Dittel
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

10.  Calcium mobilization and Rac1 activation are required for VCAM-1 (vascular cell adhesion molecule-1) stimulation of NADPH oxidase activity.

Authors:  Joan M Cook-Mills; Jacob D Johnson; Tracy L Deem; Atsuo Ochi; Lei Wang; Yi Zheng
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.